Docetaxel is an anti-neoplastic agent commonly used to treat major solid tumors. Common toxicities of docetaxel include neutropenia, alopecia, nausea and vomiting. While docetaxel is typically considered an irritant, we present the case report of a 54-year-old female with high-grade undifferentiated uterine sarcoma who experienced a standard infusion reaction during a docetaxel infusion, followed by an atypical, delayed vesicant-type reaction, without a clear extravasation history.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7519356 | PMC |
| http://dx.doi.org/10.1016/j.gore.2020.100640 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Linear Vesicles and Bulla along the Course of the Cephalic Vein: A Rare Presentation of Vesicant-type Reaction following Intravenous Docetaxel Infusion.
Indian Dermatol Online J
May 2024
Department of Dermatology and Venereology, Government Medical College Trivandrum, Kerala, India.
Bullous vesicant-type reaction to docetaxel along the venous tract: A case report.
Gynecol Oncol Rep
November 2020
Division of Gynecologic Oncology, Juravinski Hospital & Cancer Centre, Department of Obstetrics and Gynecology, McMaster University, Hamilton, Ontario, Canada.
Docetaxel is an anti-neoplastic agent commonly used to treat major solid tumors. Common toxicities of docetaxel include neutropenia, alopecia, nausea and vomiting. While docetaxel is typically considered an irritant, we present the case report of a 54-year-old female with high-grade undifferentiated uterine sarcoma who experienced a standard infusion reaction during a docetaxel infusion, followed by an atypical, delayed vesicant-type reaction, without a clear extravasation history.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!